Your browser doesn't support javascript.
loading
Factors associated with pulmonary function decline of patients in the cystic fibrosis registry of Turkey: A retrospective cohort study.
Emiralioglu, Nagehan; Çakir, Banu; Sertçelik, Ahmet; Yalçin, Ebru; Kiper, Nural; Sen, Velat; Altintas, Derya Ufuk; Serbes, Mahir; Çokugras, Haluk; Kilinç, Ayse Ayzit; Baskan, Azer Kiliç; Hepkaya, Evrim; Yazan, Hakan; Türel, Özden; Kafi, Hale Molla; Yilmaz, Asli Imran; Ünal, Gökçen; Çaglar, Tugçe; Damadoglu, Ebru; Irmak, Ilim; Demir, Esen; Öztürk, Gökçen; Bingöl, Aysen; Basaran, Erdem; Sapan, Nihat; Aslan, Ayse Tana; Asfuroglu, Pelin; Harmanci, Koray; Köse, Mehmet; Hangül, Melih; Özdemir, Ali; Tugcu, Gökçen; Polat, Sanem Eryilmaz; Özcan, Gizem; Gayretli, Zeynep Gökçe; Keskin, Özlem; Bilgiç, Sevgi; Yüksel, Hasan; Özdogan, Sebnem; Topal, Erdem; Çaltepe, Gönül; Can, Demet; Ekren, Pervin Korkmaz; Kiliç, Mehmet; Süleyman, Ayse; Eyüboglu, Tugba Sismanlar; Cinel, Güzin; Pekcan, Sevgi; Çobanoglu, Nazan; Çakir, Erkan.
Afiliación
  • Emiralioglu N; Department of Pediatric Pulmonology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
  • Çakir B; Department of Public Health, Division of Epidemiology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
  • Sertçelik A; Department of Public Health, Division of Epidemiology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
  • Yalçin E; Department of Pediatric Pulmonology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
  • Kiper N; Department of Pediatric Pulmonology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
  • Sen V; Department of Pediatric Pulmonology, Dicle University Faculty of Medicine, Diyarbakir, Turkey.
  • Altintas DU; Department of Pediatric Allergy and Immunology, Çukurova University Faculty of Medicine, Adana, Turkey.
  • Serbes M; Department of Pediatric Allergy and Immunology, Çukurova University Faculty of Medicine, Adana, Turkey.
  • Çokugras H; Department of Pediatric Pulmonology, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Kilinç AA; Department of Pediatric Pulmonology, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Baskan AK; Department of Pediatric Pulmonology, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Hepkaya E; Department of Pediatric Pulmonology, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Yazan H; Department of Pediatric Pulmonology, Bezmi Alem University Faculty of Medicine, Istanbul, Turkey.
  • Türel Ö; Department of Pediatric Pulmonology, Bezmi Alem University Faculty of Medicine, Istanbul, Turkey.
  • Kafi HM; Department of Pediatric Pulmonology, Bezmi Alem University Faculty of Medicine, Istanbul, Turkey.
  • Yilmaz AI; Department of Pediatric Pulmonology, Necmettin Erbakan University Faculty of Medicine, Konya, Turkey.
  • Ünal G; Department of Pediatric Pulmonology, Necmettin Erbakan University Faculty of Medicine, Konya, Turkey.
  • Çaglar T; Department of Pediatric Pulmonology, Necmettin Erbakan University Faculty of Medicine, Konya, Turkey.
  • Damadoglu E; Department of Adult Pulmonology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
  • Irmak I; Department of Adult Pulmonology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
  • Demir E; Department of Pediatric Pulmonology, Ege University Faculty of Medicine, Izmir, Turkey.
  • Öztürk G; Department of Pediatric Pulmonology, Ege University Faculty of Medicine, Izmir, Turkey.
  • Bingöl A; Department of Pediatric Allergy, Immunology and Pulmonology, Akdeniz University Faculty of Medicine, Antalya, Turkey.
  • Basaran E; Department of Pediatric Allergy, Immunology and Pulmonology, Akdeniz University Faculty of Medicine, Antalya, Turkey.
  • Sapan N; Department of Pediatric Allergy, Uludag University Faculty of Medicine, Bursa, Turkey.
  • Aslan AT; Department of Pediatric Pulmonology, Gazi University Faculty of Medicine, Ankara, Turkey.
  • Asfuroglu P; Department of Pediatric Pulmonology, Gazi University Faculty of Medicine, Ankara, Turkey.
  • Harmanci K; Department of Pediatric Allergy, Osmangazi University Faculty of Medicine, Eskisehir, Turkey.
  • Köse M; Department of Pediatric Pulmonology, Erciyes University Faculty of Medicine, Kayseri, Turkey.
  • Hangül M; Department of Pediatric Pulmonology, Erciyes University Faculty of Medicine, Kayseri, Turkey.
  • Özdemir A; Department of Pediatric Pulmonology, Mersin City Hospital, Mersin, Turkey.
  • Tugcu G; Department of Pediatric Pulmonology, Ankara City Hospital, Ankara, Turkey.
  • Polat SE; Department of Pediatric Pulmonology, Ankara City Hospital, Ankara, Turkey.
  • Özcan G; Department of Pediatric Pulmonology, Ankara University Faculty of Medicine, Ankara, Turkey.
  • Gayretli ZG; Department of Pediatric Infectious Disease, Karadeniz Technical University Faculty of Medicine, Trabzon, Turkey.
  • Keskin Ö; Department of Pediatric Allergy and Immunology, Gaziantep University Faculty of Medicine, Gaziantep, Turkey.
  • Bilgiç S; Department of Pediatric Allergy and Immunology, Gaziantep University Faculty of Medicine, Gaziantep, Turkey.
  • Yüksel H; Department of Pediatric Allergy, Immunology and Pulmonology, Celal Bayar University Faculty of Medicine, Manisa, Turkey.
  • Özdogan S; Department of Pediatric Pulmonology, Sariyer Hamidiye Etfal Hospital, Istanbul, Turkey.
  • Topal E; Department of Pediatric Allergy and Immunology, Inönü University Faculty of Medicine, Malatya, Turkey.
  • Çaltepe G; Department of Pediatric Gastroenterology, Ondokuz Mayis University Faculty of Medicine, Samsun, Turkey.
  • Can D; Department of Pediatric Pulmonology, Balikesir University Faculty of Medicine, Balikesir, Turkey.
  • Ekren PK; Department of Adult Pulmonology, Ege University Faculty of Medicine, Izmir, Turkey.
  • Kiliç M; Department of Pediatric Allergy and Immunology, Firat University Faculty of Medicine, Elazig, Turkey.
  • Süleyman A; Department of Pediatric Allergy and Immunology, Istanbul University Istanbul Faculty of Medicine, Istanbul, Turkey.
  • Eyüboglu TS; Department of Pediatric Pulmonology, Gazi University Faculty of Medicine, Ankara, Turkey.
  • Cinel G; Department of Pediatric Pulmonology, Ankara City Hospital, Ankara, Turkey.
  • Pekcan S; Department of Pediatric Pulmonology, Necmettin Erbakan University Faculty of Medicine, Konya, Turkey.
  • Çobanoglu N; Department of Pediatric Pulmonology, Ankara University Faculty of Medicine, Ankara, Turkey.
  • Çakir E; Department of Pediatric Pulmonology, Istinye University Faculty of Medicine, Istanbul, Turkey.
Pediatr Pulmonol ; 2024 Jul 09.
Article en En | MEDLINE | ID: mdl-38980199
ABSTRACT

BACKGROUND:

The decline in pulmonary function is a predictor of disease progression in patients with cystic fibrosis (CF). This study aimed to determine the decline rate of percent predicted forced expiratory volume in 1 s (ppFEV1) based on the data of the CF Registry of Turkey. The secondary aim was to investigate the risk factors related to the decline in ppFEV1.

METHODS:

A retrospective cohort study of CF patients over 6 years old, with pulmonary function data over at least 2 years of follow-up was extracted from the national CF registry for years 2017-2019. Patients were classified according to disease severity and age groups. Multivariate analysis was used to predict the decline in ppFEV1 and to investigate the associated risk factors.

RESULTS:

A total of 1722 pulmonary function test results were available from 574 patients over the study period. Mean diagnostic age was older and weight for age, height for age, and body mass index z scores were significantly lower in the group of ppFEV1 < 40, while chronic Pseudomonas aeruginosa (p < .001) and mucoid P. aeruginosa colonization (p < .001) were significantly higher in this group (p < .001). Overall mean annual ppFEV1 decline was -0.97% (95% confidence interval [CI] = -0.02 to -1.92%). The mean change of ppFEV1 was significantly higher in the group with ppFEV1 ≥ 70 compared with the other (ppFEV1 < 40 and ppFEV1 40-69) two groups (p = .004). Chronic P. aeruginosa colonization (odds ratio [OR] = 1.79 95% CI = 1.26-2.54; p = .01) and initial ppFEV1 ≥ 70 (OR = 2.98 95% CI = 1.06-8.36), p = .038) were associated with significant ppFEV1 decline in the whole cohort.

CONCLUSIONS:

This data analysis recommends close follow-up of patients with normal initial ppFEV1 levels at baseline; advocates for early interventions for P. aeruginosa; and underlines the importance of nutritional interventions to slow down lung disease progression.
Palabras clave

Texto completo: 1 Colección: 01-internacional Idioma: En Revista: Pediatr Pulmonol Asunto de la revista: PEDIATRIA Año: 2024 Tipo del documento: Article País de afiliación: Turquía

Texto completo: 1 Colección: 01-internacional Idioma: En Revista: Pediatr Pulmonol Asunto de la revista: PEDIATRIA Año: 2024 Tipo del documento: Article País de afiliación: Turquía